NEW YORK (GenomeWeb News) – Zygem and Phthisis Diagnostics announced Thursday that they will collaborate on developing products for the detection of infectious pathogens in complex samples, such as stool, blood, and water.

The partnership will combine Zygem's enzymatic nucleic acid extraction technology with Phthisis' molecular diagnostic test expertise to develop products that can rapidly obtain high-quality DNA from infectious pathogens. The firms will initially focus on extracting pathogen DNA from stool.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.